test

Kenneth G. Mertz II

@Emerald Mutual Fund Advisers Trust

Latest period2024 - Q3ReportedManaged Assets$1.925BTotal holdings225
Assets growth rate0.84%Assets growth rate (2-Q avg)0.12%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Emerald Mutual Fund Advisers Trust's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 225 positions.

Assets under management

The assets under management (AUM) of Emerald Mutual Fund Advisers Trust over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.925B in assets, with a quarterly growth rate of 0.84% and a 2-quarter average growth rate of 0.12%. The portfolio is managed by Kenneth G. Mertz II, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SPXCSpx Technologies Inc
Recent Activity
New Position
0.82%
$15.624M
97,982 shares@ $159.47 avg price
CDMOAvid Bioservices Inc
Recent Activity
New Position
0.63%
$11.953M
1.05M shares@ $11.38 avg price
TTMITtm Technologies Inc
Recent Activity
New Position
0.53%
$10.12M
554,545 shares@ $18.25 avg price
UMBFUmb Financial Corp
Recent Activity
New Position
0.51%
$9.775M
92,994 shares@ $105.11 avg price
SIGISelective Insurance Group Inc
Recent Activity
New Position
0.45%
$8.656M
92,775 shares@ $93.31 avg price
CVLTCommvault Systems Inc
Recent Activity
New Position
0.42%
$7.951M
51,678 shares@ $153.85 avg price
SYRESpyre Therapeutics
Recent Activity
New Position
0.39%
$7.457M
253,550 shares@ $29.42 avg price
CWANClearwater Analytics Hds
Recent Activity
New Position
0.39%
$7.455M
295,239 shares@ $25.26 avg price
KROSKeros Therapeutics Inc
Recent Activity
New Position
0.34%
$6.539M
112,613 shares@ $58.08 avg price
BIOABioage Labs Inc
Recent Activity
New Position
0.25%
$4.772M
229,431 shares@ $20.81 avg price